{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiab2rs7ohzgc6ijcy2li5he2nsnh3qne7uin2er2ejb5a75p4mm5a",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnuuixjevcc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihonqkkm5epkzjhjtkzzg4xq5aip254dosxawy2xgm653vd4vexga"
    },
    "mimeType": "image/jpeg",
    "size": 801785
  },
  "path": "/news/2026-06-drug-apitegromab-muscle-loss-weight.html",
  "publishedAt": "2026-06-09T14:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A drug called apitegromab may help preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The findings suggest that blocking a protein that limits muscle growth may improve patient weight loss outcomes by reducing the loss of lean body mass.",
  "title": "Drug apitegromab may stop muscle loss when taking weight loss drugs"
}